HOME | CONTACT | SITE MAP |
  • ABOUT HGS
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • RESEARCH & DEVELOPMENT
      • > Human Antibody Technology
      • > Albumin-Fusion Technology
      • > Drug Development at HGS
    • MANUFACTURING
    • HGS EUROPE
    • CALENDAR OF EVENTS
    • INTERNET PRIVACY POLICY
    • LEGAL NOTICES
    • GRANTS AND RESEARCH
    • CONTACTS
  • PIPELINE
    • BENLYSTA
    • Raxibacumab
    • Mapatumumab
    • GSK Products
    • CONTACTS
  • PARTNERS
    • LEAD COMMERCIAL COLLABORATIONS
    • PRODUCT COLLABORATIONS
    • TECHNOLOGY COLLABORATIONS
    • CONTACTS
  • INVESTORS
    • CORPORATE GOVERNANCE
    • STOCK INFORMATION
    • CALENDAR OF EVENTS
    • ANNUAL MEETING
    • CORPORATE PRESENTATION
    • ANNUAL REPORTS
    • QUARTERLY RESULTS
    • SEC FILINGS
    • INSIDER TRANSACTIONS
    • ANALYST COVERAGE
    • E-MAIL ALERTS
    • INVESTOR RELATIONS CONTACT
  • NEWS
    • NEWS RELEASES
    • CALENDAR OF EVENTS
    • EMAIL ALERTS
    • MEDIA CONTACT
  • CAREERS
    • SEARCH FOR JOBS
      • Guidelines to Apply
    • WORK & LIFE AT HGS
    • DIVERSITY
    • BENEFITS
    • RECRUITER INFORMATION
Human Genome Sciences
  • INVESTORS
  • CORPORATE GOVERNANCE
  • Management
  • Board of Directors
  • Committee Composition
  • Audit Committee
  • Compensation Committee
  • Finance Committee
  • Nominating and Governance Committee
  • Code of Ethics and Business Conduct
  • Comprehensive Compliance Program
  • STOCK INFORMATION
  • CALENDAR OF EVENTS
  • ANNUAL MEETING
  • CORPORATE PRESENTATION
  • ANNUAL REPORTS
  • QUARTERLY RESULTS
  • SEC FILINGS
  • INSIDER TRANSACTIONS
  • ANALYST COVERAGE
  • EMAIL ALERTS
  • INVESTOR RELATIONS CONTACT
Code of Ethics and Business Conduct


Click here for a copy of the Human Genome Sciences Code of Ethics and Business Conduct.
 
[ Back ]

©2012 Human Genome Sciences, Inc.

Human Genome Sciences | 14200 Shady Grove Road | Rockville, MD 20850
P. 301.309.8504 | F. 301.309.8512